The FDA gave Hope Bioscience's stem cell therapy RMAT designation after clinical data suggested it may improve life for ...

A new artificial intelligence model suggests that MS should be classified along a single disease continuum rather than into ...

After her own multiple sclerosis diagnosis 10 years ago, Parisa Khosravi became an advocate and a clinician for an autoimmune ...

A generation ago, a diagnosis of multiple sclerosis was a guarantee of a debilitating disease that would leave the patient wheelchair bound, and worse. Follow UCSF’s role in what some call the golden ...

In its 20th year, the "Women Against MS Luncheon" was renamed to the "Together for a Cure Luncheon" in order to put the goalposts in sight. Since its founding, the list of FDA-approved disease ...

For decades, we had a simple story for MS, but new science on B-cells, neurodegeneration, and health disparities is forcing ...

The partnership aims to develop next-generation AI models capable of predicting disease progression and treatment response in MS, leveraging transcriptomic data from ACP's extensive biorepository.

Levels of 2 types of bacteria in your gut could help improve the diagnosis and treatment of multiple sclerosis.

A recent study reveals that over one-third of individuals with relapsing-remitting multiple sclerosis (MS) do not fully ...

There's no cure for MS, but one Colorado man living with the disease hopes his perseverance will help raise money for MS ...

Learn about infusion treatments for multiple sclerosis, how they work, how to prepare for treatment, and potential side effects.

A generation ago, most people with multiple sclerosis could expect to rely on walkers and wheelchairs or be limited to their bed within 15 years of diagnosis. Today, UC San Francisco’s discoveries are ...